Truist initiated coverage of Apollo Medical with a Hold rating and $41 price target. The analyst likes the company’s recent strategic initiatives, but awaits clarity and proof points around its expansion opportunities outside of California and its performance expanding towards full risk from partial risk.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on AMEH:
- Apollo Medical management to meet with BTIG
- Apollo Medical to acquire assets of Community Family Care Medical Group IPA
- Apollo Medical narrows FY23 EPS view to $1.10-$1.20 from $95c-$1.20
- Apollo Medical reports Q3 EPS 47c, consensus 33c
- Apollo Medical Holdings, Inc. Reports Third Quarter 2023 Results
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue